Is Merck Stock a Good Buy?
Last week Merck finally won a Vioxx case. In the case a Kentucky man claimed the now defunct and withdrawn Vioxx caused him to have a heart attack. Robert Garry Smith was on the drug a little less than four months in 2003 before having a heart attack. Merck won the case solely on the fact that Smith had many risk factors that precluded the heart attack. His factors included a family history of heart problems and coronary artery disease.